224 related articles for article (PubMed ID: 22575408)
1. Intensive insulin therapy in patients with type 1 diabetes mellitus.
Switzer SM; Moser EG; Rockler BE; Garg SK
Endocrinol Metab Clin North Am; 2012 Mar; 41(1):89-104. PubMed ID: 22575408
[TBL] [Abstract][Full Text] [Related]
2. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
3. Emerging diabetes therapies and technologies.
Moser EG; Morris AA; Garg SK
Diabetes Res Clin Pract; 2012 Jul; 97(1):16-26. PubMed ID: 22381908
[TBL] [Abstract][Full Text] [Related]
4. Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes.
Ferrannini E
Endocrinol Metab Clin North Am; 2012 Mar; 41(1):25-39. PubMed ID: 22575405
[TBL] [Abstract][Full Text] [Related]
5. Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery.
Klonoff DC
Pediatr Endocrinol Rev; 2003 Dec; 1(2):94-100. PubMed ID: 16437014
[TBL] [Abstract][Full Text] [Related]
6. Type 1 diabetes: benefits of intensive insulin therapy. Patients should control blood glucose strictly.
Prescrire Int; 2002 Apr; 11(58):61. PubMed ID: 11987320
[TBL] [Abstract][Full Text] [Related]
7. Intensive insulin regimens: evidence for benefit.
Bretzel RG
Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S8-13. PubMed ID: 15306832
[TBL] [Abstract][Full Text] [Related]
8. Insulin replacement therapy. Minimizing complications and side effects.
Fleury-Milfort E
Adv Nurse Pract; 2008 Nov; 16(11):32-9: quiz 39-40. PubMed ID: 19999054
[No Abstract] [Full Text] [Related]
9. Who needs an artificial pancreas? (？).
Winikoff J; Drexler A
J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
[TBL] [Abstract][Full Text] [Related]
10. The Scylla and Charybdis of blood glucose control in children with diabetes mellitus.
Sperling MA
J Pediatr; 1997 Mar; 130(3):339-41. PubMed ID: 9063403
[No Abstract] [Full Text] [Related]
11. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
Pickup JC
Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
[No Abstract] [Full Text] [Related]
12. Technology and the issue of cost/benefit in diabetes.
Giannini C; Mohn A; Chiarelli F
Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
[TBL] [Abstract][Full Text] [Related]
13. Devices for insulin administration.
Hill J
Nurs Times; 2003 Apr 15-21; 99(15):51-2. PubMed ID: 12733296
[TBL] [Abstract][Full Text] [Related]
14. Future trends in diabetes management.
George CM
Nephrol Nurs J; 2009; 36(5):477-83. PubMed ID: 19856809
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of automating insulin delivery for the treatment of type 1 diabetes.
Steil GM; Rebrin K; Darwin C; Hariri F; Saad MF
Diabetes; 2006 Dec; 55(12):3344-50. PubMed ID: 17130478
[TBL] [Abstract][Full Text] [Related]
16. Closed-loop system in the management of diabetes: past, present, and future.
Shah VN; Shoskes A; Tawfik B; Garg SK
Diabetes Technol Ther; 2014 Aug; 16(8):477-90. PubMed ID: 25072271
[TBL] [Abstract][Full Text] [Related]
17. Insulin therapy in Europe.
Scherbaum WA
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S50-6. PubMed ID: 12324986
[TBL] [Abstract][Full Text] [Related]
18. Noninjectable methods of insulin administration.
Cernea S; Raz I
Timely Top Med Cardiovasc Dis; 2006 Nov; 10():E29. PubMed ID: 17136235
[TBL] [Abstract][Full Text] [Related]
19. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
Pozzilli P; Manfrini S; Buzzetti R; Lampeter E; Leeuw ID; Iafusco D; Prisco M; Ionescu-Tirgoviste C; Kolouskovà S; Linn T; Ludvigsson J; Madàcsy L; Mrozikiewicz AS; Mrozikiewicz PM; Podar T; Vavrinec J; Vialettes B; Visalli N; Yilmaz T; Browne PD;
Diabetes Res Clin Pract; 2005 Jun; 68(3):258-64. PubMed ID: 15936469
[TBL] [Abstract][Full Text] [Related]
20. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
